Dexcom Inc (NASDAQ:DXCM)
| 106.73 Delayed Data As of Jan 27 |  +0.08 / +0.08%Today’s Change | 66.89 Today|||52-Week Range 134.76 | -5.75% Year-to-Date |
Latest DXCM News | Press Releases
Today’s Trading
| Previous close | 106.65 |
| Today’s open | 105.88 |
| Day’s range | 105.50 - 107.73 |
| Volume | 35,142 |
| Average volume (3 months) | 2,752,817 |
| Market cap | $41.2B |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -69.41% |
| Earnings growth (this year) | +19.78% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +27.08% |
| P/E ratio | 238.5 |
| Price/Sales | 21.95 |
| Price/Book | 18.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZBHZimmer Biomet Holdin... | +0.38 | +0.30% |
| BAXBaxter International... | -0.15 | -0.34% |
| SAUHFStraumann Holding AG | +1.55 | +1.15% |
| WSTWest Pharmaceutical ... | -0.01 | -0.00% |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | February 10, 2023 |
| EPS forecast (this quarter) | $0.27 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $154.7M |
| Net profit margin | 6.32% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
